Table 1 Patient and lesion baseline characteristics

Number of follow-up CT CAP ^a

2.6 (1.9)

2.3 (1.9)

2.7 (1.9)

Number of follow-up BSLA ^a

2.6 (2.0)

2.3 (1.9)

2.7 (2.0)

Time to progression (months) ^b

4.4 (3.0–8.5)

3.2 (2.7–6.8)

4.5 (3.2–8.8)

Number of patients with target lesion(s)

158

61

97

Average no. target lesion(s) on baseline ^a

1.3 (1.5)

2.0 (1.6)

0.8 (1.3)

Average no. non-target lesion(s) on baseline ^a

1.4 (1.0)

1.5 (1.2)

1.3 (0.8)

BSLA score (mm2)^a

88,916 (77,103)

86,989 (80,005)

89,958 (76,088)